<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
71124-0026-1
</NDCCode>
<PackageDescription>
6 mL in 1 VIAL, SINGLE-DOSE (71124-0026-1)
</PackageDescription>
<NDC11Code>
71124-0026-01
</NDC11Code>
<ProductNDC>
71124-0026
</ProductNDC>
<ProductTypeName>
DRUG FOR FURTHER PROCESSING
</ProductTypeName>
<ProprietaryName/>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Ublituximab
</NonProprietaryName>
<DosageFormName>
SOLUTION
</DosageFormName>
<RouteName/>
<StartMarketingDate>
20221228
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
DRUG FOR FURTHER PROCESSING
</MarketingCategoryName>
<ApplicationNumber/>
<LabelerName>
Samsung BioLogics Co. LTD
</LabelerName>
<SubstanceName>
UBLITUXIMAB
</SubstanceName>
<StrengthNumber>
150
</StrengthNumber>
<StrengthUnit>
mg/6mL
</StrengthUnit>
<Pharm_Classes/>
<DEASchedule/>
<Status>
Unfinished
</Status>
<LastUpdate>
2023-01-07
</LastUpdate>
<PackageNdcExcludeFlag/>
<ProductNdcExcludeFlag/>
<ListingRecordCertifiedThrough>
20241231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
28-DEC-22
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage/>
</NDC>